Global Non-Invasive Ventilators Market By Product (Non-invasive Positive-pressure Ventilator (PPV) (Continuous Positive Airway Pressure (CPAP), Bilevel Positive Pressure(BiPAP), Auto-Adjusting Positive Airway Pressure (APAP)), Non-invasive Negative Pressure Ventilator (NPV)), By Application (COPD and Asthma, Respiratory Distress Syndrome, Pulmonary Edema, Obstructive Sleep Apnea, Obesity Hypoventilation Syndrome, Others), By End Users (Hospitals and Clinics, Ambulatory Surgical Centers), By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2023 – 2031

Report ID :AMI-1657 | Category : Healthcare | Published Date : August, 2023 | Pages : 402 | Format :PDF

Global Non-Invasive Ventilators Market Registered for US$ 2.34 Billion in 2022, Expanding at a CAGR of 5.9% from 2023-2031.

Non-invasive ventilators are medical devices designed to provide breathing support to patients without the need for intubation or invasive procedures. These devices deliver respiratory assistance through a mask or nasal interface, creating positive airway pressure to improve oxygenation and carbon dioxide elimination. Non-invasive ventilation (NIV) is commonly used for patients with respiratory conditions like chronic obstructive pulmonary disease (COPD), acute respiratory failure, and sleep-related breathing disorders. NIV helps alleviate breathing difficulties, reduces the work of breathing, and improves ventilation without the risks associated with invasive methods. By supporting respiratory function, non-invasive ventilators play a critical role in enhancing patient comfort, preventing complications, and facilitating recovery in various clinical settings, including intensive care units, emergency departments, and home care environments.

Among types in 2022, non-invasive positive-pressure ventilators (PPV) segment dominates the global non-invasive ventilators market. PPVs are the most commonly used type of non-invasive ventilators due to their effectiveness in providing respiratory support to patients. These devices deliver air or oxygen under positive pressure to keep the airways open and improve ventilation. PPVs are widely used for conditions like chronic respiratory failure, acute exacerbations of respiratory conditions, and sleep apnea.

COVID-19 Impact Analysis on Global Non-Invasive Ventilators Market

The pandemic led to a surge in the number of severe COVID-19 cases, with many patients experiencing respiratory distress. Non-invasive ventilators played a crucial role in providing respiratory support to COVID-19 patients, especially those with mild to moderate respiratory symptoms. The increased demand for non-invasive ventilators market to treat COVID-19 patients led to supply chain disruptions and challenges in meeting the sudden surge in global demand.

Global Non-Invasive Ventilators Market Revenue & Forecast, (US$ Million), 2015 – 2031

Global Non-Invasive Ventilators Market

The increasing incidence of respiratory disorders, such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, is driving the demand for non-invasive ventilators market. According to the World Health Organization (WHO), an estimated 65 million people suffer from moderate to severe COPD globally. Additionally, the American Academy of Sleep Medicine reported that nearly 26% of adults have sleep apnea. The rising number of respiratory disorder cases is fueling the need for non-invasive ventilators as effective tools for respiratory support, especially for patients who do not require invasive ventilation. The cost of non-invasive ventilators can be a significant restraint in their widespread adoption, especially in developing regions. High-quality non-invasive ventilators equipped with advanced features can be expensive, putting a financial burden on healthcare facilities and patients. While these devices offer several benefits in terms of patient comfort and reduced risks compared to invasive ventilation, their cost may limit accessibility, particularly in resource-constrained healthcare systems. The need for cost-effective solutions and affordable options remains crucial to ensure broader access to non-invasive ventilators.

The application segment of COPD and asthma dominated the global non-invasive ventilators market in 2022. Chronic obstructive pulmonary disease (COPD) and asthma are prevalent respiratory conditions affecting millions of people worldwide. According to the World Health Organization (WHO), around 235 million people suffer from asthma, and COPD is a leading cause of death globally, accounting for over 3 million deaths annually. Non-invasive ventilators are widely used in the management of COPD and asthma to provide respiratory support and alleviate breathing difficulties.

North America dominated the global non-invasive ventilators market in 2022. The region accounted for a substantial share of the global non-invasive ventilators market revenue, driven by the prevalence of respiratory disorders, such as COPD and sleep apnea. According to the American Lung Association, COPD affects approximately 16 million Americans, making it one of the leading chronic diseases in the U.S.

Competitive Landscape

The report provides both, qualitative and quantitative research of global non-invasive ventilators market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.

Some of the players operating in the global non-invasive ventilators market are

  • Airon Corporation
  • Dragerwerk AG & Co. KGaA
  • Fisher & Paykel Healthcare Limited
  • Getinge AB
  • Hamilton Company
  • heyer medical AG
  • Koninklijke Philips N.V.
  • Phoenix Medical Systems
  • ResMed
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Smiths Group plc
  • Teleflex Incorporated
  • Other Industry Participants

Global Non-Invasive Ventilators Market:

By Product

  • Non-invasive Positive-pressure Ventilator (PPV)

Continuous Positive Airway Pressure (CPAP)

Bilevel Positive Pressure(BiPAP)

Auto-Adjusting Positive Airway Pressure (APAP)

  • Non-invasive Negative Pressure Ventilator (NPV)

By Application

  • COPD and Asthma
  • Respiratory Distress Syndrome
  • Pulmonary Edema
  • Obstructive Sleep Apnea
  • Obesity Hypoventilation Syndrome
  • Others

By End Users

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)

Table of Contents

1.    Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2015 - 2021

1.2.2. Base Year: 2022

1.2.3. Forecast Years: 2023 – 2031

2.    Key Target Audiences

3.    Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4.    Recommendations and Insights from AMI’s Perspective**

5.    Holistic Overview of Non-Invasive Ventilators Market

6.    Market Synopsis:  Non-Invasive Ventilators Market

7.    Non-Invasive Ventilators Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.2.4. Challenges

7.3. Trends in Non-Invasive Ventilators Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Non-Invasive Ventilators Market

7.6. Porter’s Five Force Analysis

7.7. Impact of Covid-19 on Non-Invasive Ventilators Market

8.    Global Non-Invasive Ventilators Market Analysis and Forecasts, 2023 - 2031

8.1. Overview

8.1.1. Global Non-Invasive Ventilators Market Revenue (US$ Mn)

8.2. Global Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

8.2.1. Non-invasive Positive-pressure Ventilator (PPV) (Definition, Market Estimation and Penetration, 2015 - 2022, Market Estimation (2015 - 2022), Market Forecast (2023 - 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Continuous Positive Airway Pressure (CPAP), Bilevel Positive Pressure(BiPAP), Auto-Adjusting Positive Airway Pressure (APAP))

8.2.1.1.    Continuous Positive Airway Pressure (CPAP)

8.2.1.2.    Bilevel Positive Pressure(BiPAP)

8.2.1.3.    Auto-Adjusting Positive Airway Pressure (APAP)

8.2.2. Non-invasive Negative Pressure Ventilator (NPV)

8.2.2.1.    Definition

8.2.2.2.    Market Estimation and Penetration, 2015 - 2022

8.2.2.3.    Market Forecast, 2023 - 2031

8.2.2.4.    Compound Annual Growth Rate (CAGR)

8.2.2.5.    Regional Bifurcation

8.2.2.5.1.    North America

8.2.2.5.1.1. Market Estimation, 2015 - 2022

8.2.2.5.1.2. Market Forecast, 2023 - 2031

8.2.2.5.2.    Europe

8.2.2.5.2.1. Market Estimation, 2015 - 2022

8.2.2.5.2.2. Market Forecast, 2023 - 2031

8.2.2.5.3.    Asia Pacific

8.2.2.5.3.1. Market Estimation, 2015 - 2022

8.2.2.5.3.2. Market Forecast, 2023 - 2031

8.2.2.5.4.    Middle East and Africa

8.2.2.5.4.1. Market Estimation, 2015 - 2022

8.2.2.5.4.2. Market Forecast, 2023 - 2031

8.2.2.5.5.    Latin America

8.2.2.5.5.1. Market Estimation, 2015 - 2022

8.2.2.5.5.2. Market Forecast, 2023 - 2031

8.3. Key Segment for Channeling Investments

8.3.1. By Product

9.    Global Non-Invasive Ventilators Market Analysis and Forecasts, 2023 - 2031

9.1. Overview

9.2. Global Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

9.2.1. COPD and Asthma

9.2.1.1.    Definition

9.2.1.2.    Market Estimation and Penetration, 2015 - 2022

9.2.1.3.    Market Forecast, 2023 - 2031

9.2.1.4.    Compound Annual Growth Rate (CAGR)

9.2.1.5.    Regional Bifurcation

9.2.1.5.1.    North America

9.2.1.5.1.1. Market Estimation, 2015 - 2022

9.2.1.5.1.2. Market Forecast, 2023 - 2031

9.2.1.5.2.    Europe

9.2.1.5.2.1. Market Estimation, 2015 - 2022

9.2.1.5.2.2. Market Forecast, 2023 - 2031

9.2.1.5.3.    Asia Pacific

9.2.1.5.3.1. Market Estimation, 2015 - 2022

9.2.1.5.3.2. Market Forecast, 2023 - 2031

9.2.1.5.4.    Middle East and Africa

9.2.1.5.4.1. Market Estimation, 2015 - 2022

9.2.1.5.4.2. Market Forecast, 2023 - 2031

9.2.1.5.5.    Latin America

9.2.1.5.5.1. Market Estimation, 2015 - 2022

9.2.1.5.5.2. Market Forecast, 2023 - 2031

9.2.2. Respiratory Distress Syndrome

9.2.2.1.    Definition

9.2.2.2.    Market Estimation and Penetration, 2015 - 2022

9.2.2.3.    Market Forecast, 2023 - 2031

9.2.2.4.    Compound Annual Growth Rate (CAGR)

9.2.2.5.    Regional Bifurcation

9.2.2.5.1.    North America

9.2.2.5.1.1. Market Estimation, 2015 - 2022

9.2.2.5.1.2. Market Forecast, 2023 - 2031

9.2.2.5.2.    Europe

9.2.2.5.2.1. Market Estimation, 2015 - 2022

9.2.2.5.2.2. Market Forecast, 2023 - 2031

9.2.2.5.3.    Asia Pacific

9.2.2.5.3.1. Market Estimation, 2015 - 2022

9.2.2.5.3.2. Market Forecast, 2023 - 2031

9.2.2.5.4.    Middle East and Africa

9.2.2.5.4.1. Market Estimation, 2015 - 2022

9.2.2.5.4.2. Market Forecast, 2023 - 2031

9.2.2.5.5.    Latin America

9.2.2.5.5.1. Market Estimation, 2015 - 2022

9.2.2.5.5.2. Market Forecast, 2023 - 2031

9.2.3. Pulmonary Edema

9.2.3.1.    Definition

9.2.3.2.    Market Estimation and Penetration, 2015 - 2022

9.2.3.3.    Market Forecast, 2023 - 2031

9.2.3.4.    Compound Annual Growth Rate (CAGR)

9.2.3.5.    Regional Bifurcation

9.2.3.5.1.    North America

9.2.3.5.1.1. Market Estimation, 2015 - 2022

9.2.3.5.1.2. Market Forecast, 2023 - 2031

9.2.3.5.2.    Europe

9.2.3.5.2.1. Market Estimation, 2015 - 2022

9.2.3.5.2.2. Market Forecast, 2023 - 2031

9.2.3.5.3.    Asia Pacific

9.2.3.5.3.1. Market Estimation, 2015 - 2022

9.2.3.5.3.2. Market Forecast, 2023 - 2031

9.2.3.5.4.    Middle East and Africa

9.2.3.5.4.1. Market Estimation, 2015 - 2022

9.2.3.5.4.2. Market Forecast, 2023 - 2031

9.2.3.5.5.    Latin America

9.2.3.5.5.1. Market Estimation, 2015 - 2022

9.2.3.5.5.2. Market Forecast, 2023 - 2031

9.2.4. Obstructive Sleep Apnea

9.2.4.1.    Definition

9.2.4.2.    Market Estimation and Penetration, 2015 - 2022

9.2.4.3.    Market Forecast, 2023 - 2031

9.2.4.4.    Compound Annual Growth Rate (CAGR)

9.2.4.5.    Regional Bifurcation

9.2.4.5.1.    North America

9.2.4.5.1.1. Market Estimation, 2015 - 2022

9.2.4.5.1.2. Market Forecast, 2023 - 2031

9.2.4.5.2.    Europe

9.2.4.5.2.1. Market Estimation, 2015 - 2022

9.2.4.5.2.2. Market Forecast, 2023 - 2031

9.2.4.5.3.    Asia Pacific

9.2.4.5.3.1. Market Estimation, 2015 - 2022

9.2.4.5.3.2. Market Forecast, 2023 - 2031

9.2.4.5.4.    Middle East and Africa

9.2.4.5.4.1. Market Estimation, 2015 - 2022

9.2.4.5.4.2. Market Forecast, 2023 - 2031

9.2.4.5.5.    Latin America

9.2.4.5.5.1. Market Estimation, 2015 - 2022

9.2.4.5.5.2. Market Forecast, 2023 - 2031

9.2.5. Obesity Hypoventilation Syndrome

9.2.5.1.    Definition

9.2.5.2.    Market Estimation and Penetration, 2015 - 2022

9.2.5.3.    Market Forecast, 2023 - 2031

9.2.5.4.    Compound Annual Growth Rate (CAGR)

9.2.5.5.    Regional Bifurcation

9.2.5.5.1.    North America

9.2.5.5.1.1. Market Estimation, 2015 - 2022

9.2.5.5.1.2. Market Forecast, 2023 - 2031

9.2.5.5.2.    Europe

9.2.5.5.2.1. Market Estimation, 2015 - 2022

9.2.5.5.2.2. Market Forecast, 2023 - 2031

9.2.5.5.3.    Asia Pacific

9.2.5.5.3.1. Market Estimation, 2015 - 2022

9.2.5.5.3.2. Market Forecast, 2023 - 2031

9.2.5.5.4.    Middle East and Africa

9.2.5.5.4.1. Market Estimation, 2015 - 2022

9.2.5.5.4.2. Market Forecast, 2023 - 2031

9.2.5.5.5.    Latin America

9.2.5.5.5.1. Market Estimation, 2015 - 2022

9.2.5.5.5.2. Market Forecast, 2023 - 2031

9.2.6. Others

9.2.6.1.    Definition

9.2.6.2.    Market Estimation and Penetration, 2015 - 2022

9.2.6.3.    Market Forecast, 2023 - 2031

9.2.6.4.    Compound Annual Growth Rate (CAGR)

9.2.6.5.    Regional Bifurcation

9.2.6.5.1.    North America

9.2.6.5.1.1. Market Estimation, 2015 - 2022

9.2.6.5.1.2. Market Forecast, 2023 - 2031

9.2.6.5.2.    Europe

9.2.6.5.2.1. Market Estimation, 2015 - 2022

9.2.6.5.2.2. Market Forecast, 2023 - 2031

9.2.6.5.3.    Asia Pacific

9.2.6.5.3.1. Market Estimation, 2015 - 2022

9.2.6.5.3.2. Market Forecast, 2023 - 2031

9.2.6.5.4.    Middle East and Africa

9.2.6.5.4.1. Market Estimation, 2015 - 2022

9.2.6.5.4.2. Market Forecast, 2023 - 2031

9.2.6.5.5.    Latin America

9.2.6.5.5.1. Market Estimation, 2015 - 2022

9.2.6.5.5.2. Market Forecast, 2023 - 2031

9.3. Key Segment for Channeling Investments

9.3.1. By Application

10. Global Non-Invasive Ventilators Market Analysis and Forecasts, 2023 - 2031

10.1. Overview

10.2. Global Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

10.2.1. Hospitals and Clinics

10.2.1.1.  Definition

10.2.1.2.  Market Estimation and Penetration, 2015 - 2022

10.2.1.3.  Market Forecast, 2023 - 2031

10.2.1.4.  Compound Annual Growth Rate (CAGR)

10.2.1.5.  Regional Bifurcation

10.2.1.5.1.  North America

10.2.1.5.1.1. Market Estimation, 2015 - 2022

10.2.1.5.1.2. Market Forecast, 2023 - 2031

10.2.1.5.2.  Europe

10.2.1.5.2.1. Market Estimation, 2015 - 2022

10.2.1.5.2.2. Market Forecast, 2023 - 2031

10.2.1.5.3.  Asia Pacific

10.2.1.5.3.1. Market Estimation, 2015 - 2022

10.2.1.5.3.2. Market Forecast, 2023 - 2031

10.2.1.5.4.  Middle East and Africa

10.2.1.5.4.1. Market Estimation, 2015 - 2022

10.2.1.5.4.2. Market Forecast, 2023 - 2031

10.2.1.5.5.  Latin America

10.2.1.5.5.1. Market Estimation, 2015 - 2022

10.2.1.5.5.2. Market Forecast, 2023 - 2031

10.2.2. Ambulatory Surgical Centers

10.2.2.1.  Definition

10.2.2.2.  Market Estimation and Penetration, 2015 - 2022

10.2.2.3.  Market Forecast, 2023 - 2031

10.2.2.4.  Compound Annual Growth Rate (CAGR)

10.2.2.5.  Regional Bifurcation

10.2.2.5.1.  North America

10.2.2.5.1.1. Market Estimation, 2015 - 2022

10.2.2.5.1.2. Market Forecast, 2023 - 2031

10.2.2.5.2.  Europe

10.2.2.5.2.1. Market Estimation, 2015 - 2022

10.2.2.5.2.2. Market Forecast, 2023 - 2031

10.2.2.5.3.  Asia Pacific

10.2.2.5.3.1. Market Estimation, 2015 - 2022

10.2.2.5.3.2. Market Forecast, 2023 - 2031

10.2.2.5.4.  Middle East and Africa

10.2.2.5.4.1. Market Estimation, 2015 - 2022

10.2.2.5.4.2. Market Forecast, 2023 - 2031

10.2.2.5.5.  Latin America

10.2.2.5.5.1. Market Estimation, 2015 - 2022

10.2.2.5.5.2. Market Forecast, 2023 - 2031

10.2.3. Others

10.2.3.1.  Definition

10.2.3.2.  Market Estimation and Penetration, 2015 - 2022

10.2.3.3.  Market Forecast, 2023 - 2031

10.2.3.4.  Compound Annual Growth Rate (CAGR)

10.2.3.5.  Regional Bifurcation

10.2.3.5.1.  North America

10.2.3.5.1.1. Market Estimation, 2015 - 2022

10.2.3.5.1.2. Market Forecast, 2023 - 2031

10.2.3.5.2.  Europe

10.2.3.5.2.1. Market Estimation, 2015 - 2022

10.2.3.5.2.2. Market Forecast, 2023 - 2031

10.2.3.5.3.  Asia Pacific

10.2.3.5.3.1. Market Estimation, 2015 - 2022

10.2.3.5.3.2. Market Forecast, 2023 - 2031

10.2.3.5.4.  Middle East and Africa

10.2.3.5.4.1. Market Estimation, 2015 - 2022

10.2.3.5.4.2. Market Forecast, 2023 - 2031

10.2.3.5.5.  Latin America

10.2.3.5.5.1. Market Estimation, 2015 - 2022

10.2.3.5.5.2. Market Forecast, 2023 - 2031

10.3. Key Segment for Channeling Investments

10.3.1. By End Users

11. North America Non-Invasive Ventilators Market Analysis and Forecasts, 2023 - 2031

11.1. Overview

11.1.1. North America Non-Invasive Ventilators Market Revenue (US$ Mn)

11.2. North America Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

11.2.1. Non-invasive Positive-pressure Ventilator (PPV)

11.2.1.1.  Continuous Positive Airway Pressure (CPAP)

11.2.1.2.  Bilevel Positive Pressure(BiPAP)

11.2.1.3.  Auto-Adjusting Positive Airway Pressure (APAP)

11.2.2. Non-invasive Negative Pressure Ventilator (NPV)

11.3. North America Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

11.3.1. COPD and Asthma

11.3.2. Respiratory Distress Syndrome

11.3.3. Pulmonary Edema

11.3.4. Obstructive Sleep Apnea

11.3.5. Obesity Hypoventilation Syndrome

11.3.6. Others

11.4. North America Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

11.4.1. Hospitals and Clinics

11.4.2. Ambulatory Surgical Centers

11.4.3. Others

11.5. North America Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Country

11.5.1. U.S

11.5.1.1.  U.S Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

11.5.1.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

11.5.1.1.1.1. Continuous Positive Airway Pressure (CPAP)

11.5.1.1.1.2. Bilevel Positive Pressure(BiPAP)

11.5.1.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

11.5.1.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

11.5.1.2.  U.S Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

11.5.1.2.1.  COPD and Asthma

11.5.1.2.2.  Respiratory Distress Syndrome

11.5.1.2.3.  Pulmonary Edema

11.5.1.2.4.  Obstructive Sleep Apnea

11.5.1.2.5.  Obesity Hypoventilation Syndrome

11.5.1.2.6.  Others

11.5.1.3.  U.S Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

11.5.1.3.1.  Hospitals and Clinics

11.5.1.3.2.  Ambulatory Surgical Centers

11.5.1.3.3.  Others

11.5.2. Canada

11.5.2.1.  Canada Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

11.5.2.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

11.5.2.1.1.1. Continuous Positive Airway Pressure (CPAP)

11.5.2.1.1.2. Bilevel Positive Pressure(BiPAP)

11.5.2.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

11.5.2.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

11.5.2.2.  Canada Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

11.5.2.2.1.  COPD and Asthma

11.5.2.2.2.  Respiratory Distress Syndrome

11.5.2.2.3.  Pulmonary Edema

11.5.2.2.4.  Obstructive Sleep Apnea

11.5.2.2.5.  Obesity Hypoventilation Syndrome

11.5.2.2.6.  Others

11.5.2.3.  Canada Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

11.5.2.3.1.  Hospitals and Clinics

11.5.2.3.2.  Ambulatory Surgical Centers

11.5.2.3.3.  Others

11.5.3. Mexico

11.5.3.1.  Mexico Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

11.5.3.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

11.5.3.1.1.1. Continuous Positive Airway Pressure (CPAP)

11.5.3.1.1.2. Bilevel Positive Pressure(BiPAP)

11.5.3.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

11.5.3.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

11.5.3.2.  Mexico Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

11.5.3.2.1.  COPD and Asthma

11.5.3.2.2.  Respiratory Distress Syndrome

11.5.3.2.3.  Pulmonary Edema

11.5.3.2.4.  Obstructive Sleep Apnea

11.5.3.2.5.  Obesity Hypoventilation Syndrome

11.5.3.2.6.  Others

11.5.3.3.  Mexico Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

11.5.3.3.1.  Hospitals and Clinics

11.5.3.3.2.  Ambulatory Surgical Centers

11.5.3.3.3.  Others

11.5.4. Rest of North America

11.5.4.1.  Rest of North America Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

11.5.4.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

11.5.4.1.1.1. Continuous Positive Airway Pressure (CPAP)

11.5.4.1.1.2. Bilevel Positive Pressure(BiPAP)

11.5.4.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

11.5.4.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

11.5.4.2.  Rest of North America Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

11.5.4.2.1.  COPD and Asthma

11.5.4.2.2.  Respiratory Distress Syndrome

11.5.4.2.3.  Pulmonary Edema

11.5.4.2.4.  Obstructive Sleep Apnea

11.5.4.2.5.  Obesity Hypoventilation Syndrome

11.5.4.2.6.  Others

11.5.4.3.  Rest of North America Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

11.5.4.3.1.  Hospitals and Clinics

11.5.4.3.2.  Ambulatory Surgical Centers

11.5.4.3.3.  Others

11.6. Key Segment for Channeling Investments

11.6.1. By Country

11.6.2. By Product

11.6.3. By Application

11.6.4. By End Users

12. Europe Non-Invasive Ventilators Market Analysis and Forecasts, 2023 - 2031

12.1. Overview

12.1.1. Europe Non-Invasive Ventilators Market Revenue (US$ Mn)

12.2. Europe Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

12.2.1. Non-invasive Positive-pressure Ventilator (PPV)

12.2.1.1.  Continuous Positive Airway Pressure (CPAP)

12.2.1.2.  Bilevel Positive Pressure(BiPAP)

12.2.1.3.  Auto-Adjusting Positive Airway Pressure (APAP)

12.2.2. Non-invasive Negative Pressure Ventilator (NPV)

12.3. Europe Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

12.3.1. COPD and Asthma

12.3.2. Respiratory Distress Syndrome

12.3.3. Pulmonary Edema

12.3.4. Obstructive Sleep Apnea

12.3.5. Obesity Hypoventilation Syndrome

12.3.6. Others

12.4. Europe Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

12.4.1. Hospitals and Clinics

12.4.2. Ambulatory Surgical Centers

12.4.3. Others

12.5. Europe Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Country

12.5.1. France

12.5.1.1.  France Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

12.5.1.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

12.5.1.1.1.1. Continuous Positive Airway Pressure (CPAP)

12.5.1.1.1.2. Bilevel Positive Pressure(BiPAP)

12.5.1.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

12.5.1.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

12.5.1.2.  France Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

12.5.1.2.1.  COPD and Asthma

12.5.1.2.2.  Respiratory Distress Syndrome

12.5.1.2.3.  Pulmonary Edema

12.5.1.2.4.  Obstructive Sleep Apnea

12.5.1.2.5.  Obesity Hypoventilation Syndrome

12.5.1.2.6.  Others

12.5.1.3.  France Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

12.5.1.3.1.  Hospitals and Clinics

12.5.1.3.2.  Ambulatory Surgical Centers

12.5.1.3.3.  Others

12.5.2. The UK

12.5.2.1.  The UK Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

12.5.2.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

12.5.2.1.1.1. Continuous Positive Airway Pressure (CPAP)

12.5.2.1.1.2. Bilevel Positive Pressure(BiPAP)

12.5.2.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

12.5.2.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

12.5.2.2.  The UK Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

12.5.2.2.1.  COPD and Asthma

12.5.2.2.2.  Respiratory Distress Syndrome

12.5.2.2.3.  Pulmonary Edema

12.5.2.2.4.  Obstructive Sleep Apnea

12.5.2.2.5.  Obesity Hypoventilation Syndrome

12.5.2.2.6.  Others

12.5.2.3.  The UK Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

12.5.2.3.1.  Hospitals and Clinics

12.5.2.3.2.  Ambulatory Surgical Centers

12.5.2.3.3.  Others

12.5.3. Spain

12.5.3.1.  Spain Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

12.5.3.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

12.5.3.1.1.1. Continuous Positive Airway Pressure (CPAP)

12.5.3.1.1.2. Bilevel Positive Pressure(BiPAP)

12.5.3.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

12.5.3.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

12.5.3.2.  Spain Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

12.5.3.2.1.  COPD and Asthma

12.5.3.2.2.  Respiratory Distress Syndrome

12.5.3.2.3.  Pulmonary Edema

12.5.3.2.4.  Obstructive Sleep Apnea

12.5.3.2.5.  Obesity Hypoventilation Syndrome

12.5.3.2.6.  Others

12.5.3.3.  Spain Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

12.5.3.3.1.  Hospitals and Clinics

12.5.3.3.2.  Ambulatory Surgical Centers

12.5.3.3.3.  Others

12.5.4. Germany

12.5.4.1.  Germany Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

12.5.4.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

12.5.4.1.1.1. Continuous Positive Airway Pressure (CPAP)

12.5.4.1.1.2. Bilevel Positive Pressure(BiPAP)

12.5.4.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

12.5.4.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

12.5.4.2.  Germany Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

12.5.4.2.1.  COPD and Asthma

12.5.4.2.2.  Respiratory Distress Syndrome

12.5.4.2.3.  Pulmonary Edema

12.5.4.2.4.  Obstructive Sleep Apnea

12.5.4.2.5.  Obesity Hypoventilation Syndrome

12.5.4.2.6.  Others

12.5.4.3.  Germany Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

12.5.4.3.1.  Hospitals and Clinics

12.5.4.3.2.  Ambulatory Surgical Centers

12.5.4.3.3.  Others

12.5.5. Italy

12.5.5.1.  Italy Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

12.5.5.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

12.5.5.1.1.1. Continuous Positive Airway Pressure (CPAP)

12.5.5.1.1.2. Bilevel Positive Pressure(BiPAP)

12.5.5.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

12.5.5.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

12.5.5.2.  Italy Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

12.5.5.2.1.  COPD and Asthma

12.5.5.2.2.  Respiratory Distress Syndrome

12.5.5.2.3.  Pulmonary Edema

12.5.5.2.4.  Obstructive Sleep Apnea

12.5.5.2.5.  Obesity Hypoventilation Syndrome

12.5.5.2.6.  Others

12.5.5.3.  Italy Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

12.5.5.3.1.  Hospitals and Clinics

12.5.5.3.2.  Ambulatory Surgical Centers

12.5.5.3.3.  Others

12.5.6. Nordic Countries

12.5.6.1.  Nordic Countries Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

12.5.6.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

12.5.6.1.1.1. Continuous Positive Airway Pressure (CPAP)

12.5.6.1.1.2. Bilevel Positive Pressure(BiPAP)

12.5.6.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

12.5.6.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

12.5.6.2.  Nordic Countries Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

12.5.6.2.1.  COPD and Asthma

12.5.6.2.2.  Respiratory Distress Syndrome

12.5.6.2.3.  Pulmonary Edema

12.5.6.2.4.  Obstructive Sleep Apnea

12.5.6.2.5.  Obesity Hypoventilation Syndrome

12.5.6.2.6.  Others

12.5.6.3.  Nordic Countries Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

12.5.6.3.1.  Hospitals and Clinics

12.5.6.3.2.  Ambulatory Surgical Centers

12.5.6.3.3.  Others

12.5.6.4.  Nordic Countries Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Country

12.5.6.4.1.  Denmark

12.5.6.4.2.  Finland

12.5.6.4.3.  Iceland

12.5.6.4.4.  Sweden

12.5.6.4.5.  Norway

12.5.7. Benelux Union

12.5.7.1.  Benelux Union Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

12.5.7.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

12.5.7.1.1.1. Continuous Positive Airway Pressure (CPAP)

12.5.7.1.1.2. Bilevel Positive Pressure(BiPAP)

12.5.7.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

12.5.7.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

12.5.7.2.  Benelux Union Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

12.5.7.2.1.  COPD and Asthma

12.5.7.2.2.  Respiratory Distress Syndrome

12.5.7.2.3.  Pulmonary Edema

12.5.7.2.4.  Obstructive Sleep Apnea

12.5.7.2.5.  Obesity Hypoventilation Syndrome

12.5.7.2.6.  Others

12.5.7.3.  Benelux Union Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

12.5.7.3.1.  Hospitals and Clinics

12.5.7.3.2.  Ambulatory Surgical Centers

12.5.7.3.3.  Others

12.5.7.4.  Benelux Union Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Country

12.5.7.4.1.  Belgium

12.5.7.4.2.  The Netherlands

12.5.7.4.3.  Luxembourg

12.5.8. Rest of Europe

12.5.8.1.  Rest of Europe Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

12.5.8.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

12.5.8.1.1.1. Continuous Positive Airway Pressure (CPAP)

12.5.8.1.1.2. Bilevel Positive Pressure(BiPAP)

12.5.8.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

12.5.8.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

12.5.8.2.  Rest of Europe Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

12.5.8.2.1.  COPD and Asthma

12.5.8.2.2.  Respiratory Distress Syndrome

12.5.8.2.3.  Pulmonary Edema

12.5.8.2.4.  Obstructive Sleep Apnea

12.5.8.2.5.  Obesity Hypoventilation Syndrome

12.5.8.2.6.  Others

12.5.8.3.  Rest of Europe Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

12.5.8.3.1.  Hospitals and Clinics

12.5.8.3.2.  Ambulatory Surgical Centers

12.5.8.3.3.  Others

12.6. Key Segment for Channeling Investments

12.6.1. By Country

12.6.2. By Product

12.6.3. By Application

12.6.4. By End Users

13. Asia Pacific Non-Invasive Ventilators Market Analysis and Forecasts, 2023 - 2031

13.1. Overview

13.1.1. Asia Pacific Non-Invasive Ventilators Market Revenue (US$ Mn)

13.2. Asia Pacific Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

13.2.1. Non-invasive Positive-pressure Ventilator (PPV)

13.2.1.1.  Continuous Positive Airway Pressure (CPAP)

13.2.1.2.  Bilevel Positive Pressure(BiPAP)

13.2.1.3.  Auto-Adjusting Positive Airway Pressure (APAP)

13.2.2. Non-invasive Negative Pressure Ventilator (NPV)

13.3. Asia Pacific Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

13.3.1. COPD and Asthma

13.3.2. Respiratory Distress Syndrome

13.3.3. Pulmonary Edema

13.3.4. Obstructive Sleep Apnea

13.3.5. Obesity Hypoventilation Syndrome

13.3.6. Others

13.4. Asia Pacific Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

13.4.1. Hospitals and Clinics

13.4.2. Ambulatory Surgical Centers

13.4.3. Others

13.5. Asia Pacific Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Country

13.5.1. China

13.5.1.1.  China Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

13.5.1.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

13.5.1.1.1.1. Continuous Positive Airway Pressure (CPAP)

13.5.1.1.1.2. Bilevel Positive Pressure(BiPAP)

13.5.1.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

13.5.1.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

13.5.1.2.  China Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

13.5.1.2.1.  COPD and Asthma

13.5.1.2.2.  Respiratory Distress Syndrome

13.5.1.2.3.  Pulmonary Edema

13.5.1.2.4.  Obstructive Sleep Apnea

13.5.1.2.5.  Obesity Hypoventilation Syndrome

13.5.1.2.6.  Others

13.5.1.3.  China Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

13.5.1.3.1.  Hospitals and Clinics

13.5.1.3.2.  Ambulatory Surgical Centers

13.5.1.3.3.  Others

13.5.2. Japan

13.5.2.1.  Japan Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

13.5.2.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

13.5.2.1.1.1. Continuous Positive Airway Pressure (CPAP)

13.5.2.1.1.2. Bilevel Positive Pressure(BiPAP)

13.5.2.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

13.5.2.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

13.5.2.2.  Japan Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

13.5.2.2.1.  COPD and Asthma

13.5.2.2.2.  Respiratory Distress Syndrome

13.5.2.2.3.  Pulmonary Edema

13.5.2.2.4.  Obstructive Sleep Apnea

13.5.2.2.5.  Obesity Hypoventilation Syndrome

13.5.2.2.6.  Others

13.5.2.3.  Japan Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

13.5.2.3.1.  Hospitals and Clinics

13.5.2.3.2.  Ambulatory Surgical Centers

13.5.2.3.3.  Others

13.5.3. India

13.5.3.1.  India Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

13.5.3.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

13.5.3.1.1.1. Continuous Positive Airway Pressure (CPAP)

13.5.3.1.1.2. Bilevel Positive Pressure(BiPAP)

13.5.3.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

13.5.3.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

13.5.3.2.  India Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

13.5.3.2.1.  COPD and Asthma

13.5.3.2.2.  Respiratory Distress Syndrome

13.5.3.2.3.  Pulmonary Edema

13.5.3.2.4.  Obstructive Sleep Apnea

13.5.3.2.5.  Obesity Hypoventilation Syndrome

13.5.3.2.6.  Others

13.5.3.3.  India Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

13.5.3.3.1.  Hospitals and Clinics

13.5.3.3.2.  Ambulatory Surgical Centers

13.5.3.3.3.  Others

13.5.4. New Zealand

13.5.4.1.  New Zealand Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

13.5.4.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

13.5.4.1.1.1. Continuous Positive Airway Pressure (CPAP)

13.5.4.1.1.2. Bilevel Positive Pressure(BiPAP)

13.5.4.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

13.5.4.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

13.5.4.2.  New Zealand Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

13.5.4.2.1.  COPD and Asthma

13.5.4.2.2.  Respiratory Distress Syndrome

13.5.4.2.3.  Pulmonary Edema

13.5.4.2.4.  Obstructive Sleep Apnea

13.5.4.2.5.  Obesity Hypoventilation Syndrome

13.5.4.2.6.  Others

13.5.4.3.  New Zealand Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

13.5.4.3.1.  Hospitals and Clinics

13.5.4.3.2.  Ambulatory Surgical Centers

13.5.4.3.3.  Others

13.5.5. Australia

13.5.5.1.  Australia Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

13.5.5.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

13.5.5.1.1.1. Continuous Positive Airway Pressure (CPAP)

13.5.5.1.1.2. Bilevel Positive Pressure(BiPAP)

13.5.5.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

13.5.5.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

13.5.5.2.  Australia Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

13.5.5.2.1.  COPD and Asthma

13.5.5.2.2.  Respiratory Distress Syndrome

13.5.5.2.3.  Pulmonary Edema

13.5.5.2.4.  Obstructive Sleep Apnea

13.5.5.2.5.  Obesity Hypoventilation Syndrome

13.5.5.2.6.  Others

13.5.5.3.  Australia Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

13.5.5.3.1.  Hospitals and Clinics

13.5.5.3.2.  Ambulatory Surgical Centers

13.5.5.3.3.  Others

13.5.6. South Korea

13.5.6.1.  South Korea Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

13.5.6.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

13.5.6.1.1.1. Continuous Positive Airway Pressure (CPAP)

13.5.6.1.1.2. Bilevel Positive Pressure(BiPAP)

13.5.6.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

13.5.6.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

13.5.6.2.  South Korea Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

13.5.6.2.1.  COPD and Asthma

13.5.6.2.2.  Respiratory Distress Syndrome

13.5.6.2.3.  Pulmonary Edema

13.5.6.2.4.  Obstructive Sleep Apnea

13.5.6.2.5.  Obesity Hypoventilation Syndrome

13.5.6.2.6.  Others

13.5.6.3.  South Korea Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

13.5.6.3.1.  Hospitals and Clinics

13.5.6.3.2.  Ambulatory Surgical Centers

13.5.6.3.3.  Others

13.5.7. Southeast Asia

13.5.7.1.  Southeast Asia Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

13.5.7.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

13.5.7.1.1.1. Continuous Positive Airway Pressure (CPAP)

13.5.7.1.1.2. Bilevel Positive Pressure(BiPAP)

13.5.7.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

13.5.7.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

13.5.7.2.  Southeast Asia Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

13.5.7.2.1.  COPD and Asthma

13.5.7.2.2.  Respiratory Distress Syndrome

13.5.7.2.3.  Pulmonary Edema

13.5.7.2.4.  Obstructive Sleep Apnea

13.5.7.2.5.  Obesity Hypoventilation Syndrome

13.5.7.2.6.  Others

13.5.7.3.  Southeast Asia Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

13.5.7.3.1.  Hospitals and Clinics

13.5.7.3.2.  Ambulatory Surgical Centers

13.5.7.3.3.  Others

13.5.7.4.  Southeast Asia Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Country

13.5.7.4.1.  Indonesia

13.5.7.4.2.  Thailand

13.5.7.4.3.  Malaysia

13.5.7.4.4.  Singapore

13.5.7.4.5.  Rest of Southeast Asia

13.5.8. Rest of Asia Pacific

13.5.8.1.  Rest of Asia Pacific Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

13.5.8.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

13.5.8.1.1.1. Continuous Positive Airway Pressure (CPAP)

13.5.8.1.1.2. Bilevel Positive Pressure(BiPAP)

13.5.8.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

13.5.8.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

13.5.8.2.  Rest of Asia Pacific Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

13.5.8.2.1.  COPD and Asthma

13.5.8.2.2.  Respiratory Distress Syndrome

13.5.8.2.3.  Pulmonary Edema

13.5.8.2.4.  Obstructive Sleep Apnea

13.5.8.2.5.  Obesity Hypoventilation Syndrome

13.5.8.2.6.  Others

13.5.8.3.  Rest of Asia Pacific Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

13.5.8.3.1.  Hospitals and Clinics

13.5.8.3.2.  Ambulatory Surgical Centers

13.5.8.3.3.  Others

13.6. Key Segment for Channeling Investments

13.6.1. By Country

13.6.2. By Product

13.6.3. By Application

13.6.4. By End Users

14. Middle East and Africa Non-Invasive Ventilators Market Analysis and Forecasts, 2023 - 2031

14.1. Overview

14.1.1. Middle East and Africa Non-Invasive Ventilators Market Revenue (US$ Mn)

14.2. Middle East and Africa Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

14.2.1. Non-invasive Positive-pressure Ventilator (PPV)

14.2.1.1.  Continuous Positive Airway Pressure (CPAP)

14.2.1.2.  Bilevel Positive Pressure(BiPAP)

14.2.1.3.  Auto-Adjusting Positive Airway Pressure (APAP)

14.2.2. Non-invasive Negative Pressure Ventilator (NPV)

14.3. Middle East and Africa Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

14.3.1. COPD and Asthma

14.3.2. Respiratory Distress Syndrome

14.3.3. Pulmonary Edema

14.3.4. Obstructive Sleep Apnea

14.3.5. Obesity Hypoventilation Syndrome

14.3.6. Others

14.4. Middle East and Africa Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

14.4.1. Hospitals and Clinics

14.4.2. Ambulatory Surgical Centers

14.4.3. Others

14.5. Middle East and Africa Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Country

14.5.1. Saudi Arabia

14.5.1.1.  Saudi Arabia Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

14.5.1.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

14.5.1.1.1.1. Continuous Positive Airway Pressure (CPAP)

14.5.1.1.1.2. Bilevel Positive Pressure(BiPAP)

14.5.1.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

14.5.1.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

14.5.1.2.  Saudi Arabia Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

14.5.1.2.1.  COPD and Asthma

14.5.1.2.2.  Respiratory Distress Syndrome

14.5.1.2.3.  Pulmonary Edema

14.5.1.2.4.  Obstructive Sleep Apnea

14.5.1.2.5.  Obesity Hypoventilation Syndrome

14.5.1.2.6.  Others

14.5.1.3.  Saudi Arabia Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

14.5.1.3.1.  Hospitals and Clinics

14.5.1.3.2.  Ambulatory Surgical Centers

14.5.1.3.3.  Others

14.5.2. UAE

14.5.2.1.  UAE Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

14.5.2.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

14.5.2.1.1.1. Continuous Positive Airway Pressure (CPAP)

14.5.2.1.1.2. Bilevel Positive Pressure(BiPAP)

14.5.2.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

14.5.2.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

14.5.2.2.  UAE Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

14.5.2.2.1.  COPD and Asthma

14.5.2.2.2.  Respiratory Distress Syndrome

14.5.2.2.3.  Pulmonary Edema

14.5.2.2.4.  Obstructive Sleep Apnea

14.5.2.2.5.  Obesity Hypoventilation Syndrome

14.5.2.2.6.  Others

14.5.2.3.  UAE Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

14.5.2.3.1.  Hospitals and Clinics

14.5.2.3.2.  Ambulatory Surgical Centers

14.5.2.3.3.  Others

14.5.3. Egypt

14.5.3.1.  Egypt Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

14.5.3.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

14.5.3.1.1.1. Continuous Positive Airway Pressure (CPAP)

14.5.3.1.1.2. Bilevel Positive Pressure(BiPAP)

14.5.3.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

14.5.3.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

14.5.3.2.  Egypt Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

14.5.3.2.1.  COPD and Asthma

14.5.3.2.2.  Respiratory Distress Syndrome

14.5.3.2.3.  Pulmonary Edema

14.5.3.2.4.  Obstructive Sleep Apnea

14.5.3.2.5.  Obesity Hypoventilation Syndrome

14.5.3.2.6.  Others

14.5.3.3.  Egypt Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

14.5.3.3.1.  Hospitals and Clinics

14.5.3.3.2.  Ambulatory Surgical Centers

14.5.3.3.3.  Others

14.5.4. Kuwait

14.5.4.1.  Kuwait Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

14.5.4.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

14.5.4.1.1.1. Continuous Positive Airway Pressure (CPAP)

14.5.4.1.1.2. Bilevel Positive Pressure(BiPAP)

14.5.4.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

14.5.4.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

14.5.4.2.  Kuwait Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

14.5.4.2.1.  COPD and Asthma

14.5.4.2.2.  Respiratory Distress Syndrome

14.5.4.2.3.  Pulmonary Edema

14.5.4.2.4.  Obstructive Sleep Apnea

14.5.4.2.5.  Obesity Hypoventilation Syndrome

14.5.4.2.6.  Others

14.5.4.3.  Kuwait Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

14.5.4.3.1.  Hospitals and Clinics

14.5.4.3.2.  Ambulatory Surgical Centers

14.5.4.3.3.  Others

14.5.5. South Africa

14.5.5.1.  South Africa Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

14.5.5.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

14.5.5.1.1.1. Continuous Positive Airway Pressure (CPAP)

14.5.5.1.1.2. Bilevel Positive Pressure(BiPAP)

14.5.5.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

14.5.5.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

14.5.5.2.  South Africa Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

14.5.5.2.1.  COPD and Asthma

14.5.5.2.2.  Respiratory Distress Syndrome

14.5.5.2.3.  Pulmonary Edema

14.5.5.2.4.  Obstructive Sleep Apnea

14.5.5.2.5.  Obesity Hypoventilation Syndrome

14.5.5.2.6.  Others

14.5.5.3.  South Africa Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

14.5.5.3.1.  Hospitals and Clinics

14.5.5.3.2.  Ambulatory Surgical Centers

14.5.5.3.3.  Others

14.5.6. Rest of Middle East & Africa

14.5.6.1.  Rest of Middle East & Africa Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

14.5.6.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

14.5.6.1.1.1. Continuous Positive Airway Pressure (CPAP)

14.5.6.1.1.2. Bilevel Positive Pressure(BiPAP)

14.5.6.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

14.5.6.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

14.5.6.2.  Rest of Middle East & Africa Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

14.5.6.2.1.  COPD and Asthma

14.5.6.2.2.  Respiratory Distress Syndrome

14.5.6.2.3.  Pulmonary Edema

14.5.6.2.4.  Obstructive Sleep Apnea

14.5.6.2.5.  Obesity Hypoventilation Syndrome

14.5.6.2.6.  Others

14.5.6.3.  Rest of Middle East & Africa Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

14.5.6.3.1.  Hospitals and Clinics

14.5.6.3.2.  Ambulatory Surgical Centers

14.5.6.3.3.  Others

14.6. Key Segment for Channeling Investments

14.6.1. By Country

14.6.2. By Product

14.6.3. By Application

14.6.4. By End Users

15. Latin America Non-Invasive Ventilators Market Analysis and Forecasts, 2023 - 2031

15.1. Overview

15.1.1. Latin America Non-Invasive Ventilators Market Revenue (US$ Mn)

15.2. Latin America Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

15.2.1. Non-invasive Positive-pressure Ventilator (PPV)

15.2.1.1.  Continuous Positive Airway Pressure (CPAP)

15.2.1.2.  Bilevel Positive Pressure(BiPAP)

15.2.1.3.  Auto-Adjusting Positive Airway Pressure (APAP)

15.2.2. Non-invasive Negative Pressure Ventilator (NPV)

15.3. Latin America Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

15.3.1. COPD and Asthma

15.3.2. Respiratory Distress Syndrome

15.3.3. Pulmonary Edema

15.3.4. Obstructive Sleep Apnea

15.3.5. Obesity Hypoventilation Syndrome

15.3.6. Others

15.4. Latin America Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

15.4.1. Hospitals and Clinics

15.4.2. Ambulatory Surgical Centers

15.4.3. Others

15.5. Latin America Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Country

15.5.1. Brazil

15.5.1.1.  Brazil Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

15.5.1.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

15.5.1.1.1.1. Continuous Positive Airway Pressure (CPAP)

15.5.1.1.1.2. Bilevel Positive Pressure(BiPAP)

15.5.1.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

15.5.1.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

15.5.1.2.  Brazil Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

15.5.1.2.1.  COPD and Asthma

15.5.1.2.2.  Respiratory Distress Syndrome

15.5.1.2.3.  Pulmonary Edema

15.5.1.2.4.  Obstructive Sleep Apnea

15.5.1.2.5.  Obesity Hypoventilation Syndrome

15.5.1.2.6.  Others

15.5.1.3.  Brazil Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

15.5.1.3.1.  Hospitals and Clinics

15.5.1.3.2.  Ambulatory Surgical Centers

15.5.1.3.3.  Others

15.5.2. Argentina

15.5.2.1.  Argentina Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

15.5.2.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

15.5.2.1.1.1. Continuous Positive Airway Pressure (CPAP)

15.5.2.1.1.2. Bilevel Positive Pressure(BiPAP)

15.5.2.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

15.5.2.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

15.5.2.2.  Argentina Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

15.5.2.2.1.  COPD and Asthma

15.5.2.2.2.  Respiratory Distress Syndrome

15.5.2.2.3.  Pulmonary Edema

15.5.2.2.4.  Obstructive Sleep Apnea

15.5.2.2.5.  Obesity Hypoventilation Syndrome

15.5.2.2.6.  Others

15.5.2.3.  Argentina Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

15.5.2.3.1.  Hospitals and Clinics

15.5.2.3.2.  Ambulatory Surgical Centers

15.5.2.3.3.  Others

15.5.3. Rest of Latin America

15.5.3.1.  Rest of Latin America Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Product

15.5.3.1.1.  Non-invasive Positive-pressure Ventilator (PPV)

15.5.3.1.1.1. Continuous Positive Airway Pressure (CPAP)

15.5.3.1.1.2. Bilevel Positive Pressure(BiPAP)

15.5.3.1.1.3. Auto-Adjusting Positive Airway Pressure (APAP)

15.5.3.1.2.  Non-invasive Negative Pressure Ventilator (NPV)

15.5.3.2.  Rest of Latin America Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By Application

15.5.3.2.1.  COPD and Asthma

15.5.3.2.2.  Respiratory Distress Syndrome

15.5.3.2.3.  Pulmonary Edema

15.5.3.2.4.  Obstructive Sleep Apnea

15.5.3.2.5.  Obesity Hypoventilation Syndrome

15.5.3.2.6.  Others

15.5.3.3.  Rest of Latin America Non-Invasive Ventilators Market Revenue (US$ Mn) and Forecasts, By End Users

15.5.3.3.1.  Hospitals and Clinics

15.5.3.3.2.  Ambulatory Surgical Centers

15.5.3.3.3.  Others

15.6. Key Segment for Channeling Investments

15.6.1. By Country

15.6.2. By Product

15.6.3. By Application

15.6.4. By End Users

16. Competitive Benchmarking

16.1. Brand Benchmarking

16.2. Market Share Analysis, 2022

16.3. Global Presence and Growth Strategies

16.3.1. Mergers and Acquisitions

16.3.2. Product Launches

16.3.3. Investments Trends

16.3.4. R&D Initiatives

17. Player Profiles

17.1. Airon Corporation

17.1.1. Company Details

17.1.2. Company Overview

17.1.3. Product Offerings

17.1.4. Key Developments

17.1.5. Financial Analysis

17.1.6. SWOT Analysis

17.1.7. Business Strategies

17.2. Dragerwerk AG & Co. KGaA

17.2.1. Company Details

17.2.2. Company Overview

17.2.3. Product Offerings

17.2.4. Key Developments

17.2.5. Financial Analysis

17.2.6. SWOT Analysis

17.2.7. Business Strategies

17.3. Fisher & Paykel Healthcare Limited

17.3.1. Company Details

17.3.2. Company Overview

17.3.3. Product Offerings

17.3.4. Key Developments

17.3.5. Financial Analysis

17.3.6. SWOT Analysis

17.3.7. Business Strategies

17.4. Getinge AB

17.4.1. Company Details

17.4.2. Company Overview

17.4.3. Product Offerings

17.4.4. Key Developments

17.4.5. Financial Analysis

17.4.6. SWOT Analysis

17.4.7. Business Strategies

17.5. Hamilton Company

17.5.1. Company Details

17.5.2. Company Overview

17.5.3. Product Offerings

17.5.4. Key Developments

17.5.5. Financial Analysis

17.5.6. SWOT Analysis

17.5.7. Business Strategies

17.6. heyer medical AG

17.6.1. Company Details

17.6.2. Company Overview

17.6.3. Product Offerings

17.6.4. Key Developments

17.6.5. Financial Analysis

17.6.6. SWOT Analysis

17.6.7. Business Strategies

17.7. Koninklijke Philips N.V.

17.7.1. Company Details

17.7.2. Company Overview

17.7.3. Product Offerings

17.7.4. Key Developments

17.7.5. Financial Analysis

17.7.6. SWOT Analysis

17.7.7. Business Strategies

17.8. Phoenix Medical Systems

17.8.1. Company Details

17.8.2. Company Overview

17.8.3. Product Offerings

17.8.4. Key Developments

17.8.5. Financial Analysis

17.8.6. SWOT Analysis

17.8.7. Business Strategies

17.9. ResMed

17.9.1. Company Details

17.9.2. Company Overview

17.9.3. Product Offerings

17.9.4. Key Developments

17.9.5. Financial Analysis

17.9.6. SWOT Analysis

17.9.7. Business Strategies

17.10. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

17.10.1. Company Details

17.10.2. Company Overview

17.10.3. Product Offerings

17.10.4. Key Developments

17.10.5. Financial Analysis

17.10.6. SWOT Analysis

17.10.7. Business Strategies

17.11. Smiths Group plc

17.11.1. Company Details

17.11.2. Company Overview

17.11.3. Product Offerings

17.11.4. Key Developments

17.11.5. Financial Analysis

17.11.6. SWOT Analysis

17.11.7. Business Strategies

17.12. Teleflex Incorporated

17.12.1. Company Details

17.12.2. Company Overview

17.12.3. Product Offerings

17.12.4. Key Developments

17.12.5. Financial Analysis

17.12.6. SWOT Analysis

17.12.7. Business Strategies

17.13. Other Market Participants

18. Key Findings

 

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

**Exclusive for Multi-User and Enterprise User.

 

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews  are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.  

Prominent participants in our primary research process include:

  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers

Research Methodology

Methodology

Key Inclusions

Methodology

Request A Sample

Ask for Discount

Enquiry Before Buying

Request For Customization

Purchase Options

Buy Now

Reach to us

Call us on

+91-74002-42424

Drop us an email at

sales@absolutemarketsinsights.com